12:42 PM EST - Albert Labs International Corp : Announced it has filed a provisional patent application with the United States Patent and Trademark Office for a proprietary process. Albert Labs' culturing process can significantly increase the production volumes of psilocybin medicine. The Company sees the demand for naturally produced psilocybin continuing to increase as the unmet needs for mental health treatment hit crisis levels worldwide. Albert Labs International Corp
shares C.ABRT are trading unchanged at $0.20.
